| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |